These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1112 related articles for article (PubMed ID: 26920880)

  • 1. Innate host defenses against Cryptococcus neoformans.
    Hole C; Wormley FL
    J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host immunity to Cryptococcus neoformans.
    Rohatgi S; Pirofski LA
    Future Microbiol; 2015; 10(4):565-81. PubMed ID: 25865194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
    Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
    mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology for Anti-Cryptococcal Vaccine Development.
    Chaturvedi AK; Wormley FL
    Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
    Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
    mBio; 2016 May; 7(3):. PubMed ID: 27165801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Heat-Killed
    Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
    mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of protective immunity against cryptococcosis.
    Wozniak KL; Hardison S; Olszewski M; Wormley FL
    Mycopathologia; 2012 Jun; 173(5-6):387-94. PubMed ID: 22143898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
    Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.
    Hole CR; Wormley FL
    Front Microbiol; 2012; 3():291. PubMed ID: 22973262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
    Wormley FL; Cox GM; Perfect JR
    Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in innate host immune responses to cryptococcosis.
    Garelnabi M; May RC
    Mem Inst Oswaldo Cruz; 2018; 113(7):e180060. PubMed ID: 29668826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.
    Gibson JF; Johnston SA
    Fungal Genet Biol; 2015 May; 78():76-86. PubMed ID: 25498576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Recombinant
    Specht CA; Lee CK; Huang H; Hester MM; Liu J; Luckie BA; Torres Santana MA; Mirza Z; Khoshkenar P; Abraham A; Shen ZT; Lodge JK; Akalin A; Homan J; Ostroff GR; Levitz SM
    mBio; 2017 Nov; 8(6):. PubMed ID: 29184017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcus antigens and immune responses: implications for a vaccine.
    Chaturvedi AK; Wormley FL
    Expert Rev Vaccines; 2013 Nov; 12(11):1261-72. PubMed ID: 24156284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a vaccine for Cryptococcus neoformans: principles and caveats.
    Datta K; Pirofski LA
    FEMS Yeast Res; 2006 Jun; 6(4):525-36. PubMed ID: 16696648
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Colombo AC; Rella A; Normile T; Joffe LS; Tavares PM; de S Araújo GR; Frases S; Orner EP; Farnoud AM; Fries BC; Sheridan B; Nimrichter L; Rodrigues ML; Del Poeta M
    mBio; 2019 Apr; 10(2):. PubMed ID: 30940711
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of cryptococcal virulence and persistence.
    Olszewski MA; Zhang Y; Huffnagle GB
    Future Microbiol; 2010 Aug; 5(8):1269-88. PubMed ID: 20722603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
    Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
    mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
    Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
    Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.